BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
8.86
-0.04 (-0.45%)
At close: Apr 28, 2026, 4:00 PM EDT
8.85
-0.01 (-0.12%)
After-hours: Apr 28, 2026, 6:48 PM EDT
BioCryst Pharmaceuticals Employees
BioCryst Pharmaceuticals had 435 employees as of December 31, 2025. The number of employees decreased by 145 or -25.00% compared to the previous year.
Employees
435
Change (1Y)
-145
Growth (1Y)
-25.00%
Revenue / Employee
$2,011,120
Profits / Employee
$606,577
Market Cap
2.22B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bausch Health Companies | 20,300 |
| Perrigo Company | 8,100 |
| Phibro Animal Health | 2,475 |
| HUTCHMED (China) | 1,796 |
| ANI Pharmaceuticals | 970 |
| Supernus Pharmaceuticals | 778 |
| Prestige Consumer Healthcare | 600 |
| Harrow | 373 |
BCRX News
- 18 hours ago - BioCryst to Present at Upcoming Investor Conferences - GlobeNewsWire
- 13 days ago - BioCryst to Report First Quarter 2026 Financial Results on May 6 - GlobeNewsWire
- 22 days ago - BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer - GlobeNewsWire
- 25 days ago - BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - BioCryst Pharmaceuticals Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - BioCryst Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - BioCryst Reports Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - BioCryst to Present at Upcoming Investor Conference - GlobeNewsWire